VERGA, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 579
EU - Europa 340
AS - Asia 135
SA - Sud America 1
Totale 1.055
Nazione #
US - Stati Uniti d'America 573
DE - Germania 98
IT - Italia 82
SG - Singapore 64
IE - Irlanda 45
SE - Svezia 39
CN - Cina 32
RU - Federazione Russa 29
ID - Indonesia 17
HK - Hong Kong 14
FR - Francia 12
UA - Ucraina 12
GB - Regno Unito 7
CA - Canada 6
TR - Turchia 6
FI - Finlandia 5
BE - Belgio 3
LT - Lituania 3
DK - Danimarca 2
CO - Colombia 1
CZ - Repubblica Ceca 1
IN - India 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
Totale 1.055
Città #
Ann Arbor 249
Frankfurt am Main 86
Singapore 57
Dublin 44
Chandler 36
Fairfield 26
Wilmington 26
Milan 24
Woodbridge 24
New York 20
Ashburn 17
Jakarta 17
Dearborn 15
Santa Clara 15
Hong Kong 14
Houston 10
Princeton 10
Shanghai 10
Cambridge 9
Jacksonville 7
Seattle 6
Guangzhou 5
Lawrence 5
Nanjing 5
Helsinki 4
Andover 3
Ankara 3
Bologna 3
Brussels 3
Colorado Springs 3
Falls Church 3
Fremont 3
Kocaeli 3
San Diego 3
Aurora 2
Bari 2
Bergamo 2
Boardman 2
Broni 2
Haikou 2
Lissone 2
Los Angeles 2
Munich 2
Ottawa 2
Paris 2
Romola 2
Sacramento 2
Toronto 2
Vimercate 2
Altamura 1
Barlassina 1
Beijing 1
Bogotá 1
Bonndorf 1
Cantù 1
Castiglione Delle Stiviere 1
Catania 1
Changchun 1
Changsha 1
Chennevières-sur-marne 1
Chicago 1
Chiswick 1
Corsico 1
Desio 1
Duarte 1
Edmonton 1
Hangzhou 1
Hebei 1
Hounslow 1
Kiev 1
Kunming 1
Lachine 1
Las Vegas 1
Leawood 1
London 1
Lucino 1
Manila 1
Montesilvano 1
Nanchang 1
New Kensington 1
Newark 1
North Brunswick 1
Norwalk 1
Nürnberg 1
Oakland 1
Prague 1
Pune 1
Ranica 1
Redmond 1
Rome 1
Samarate 1
San Francisco 1
Sesto San Giovanni 1
Stockholm 1
Taizhou 1
Trento 1
Treviso 1
Vidin 1
Washington 1
Totale 848
Nome #
Long-term efficacy and safety of crizotinib in relapsed ALK positive lymphoma patients: clinical and biological correlates 291
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 222
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 189
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) 140
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 98
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 66
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 56
CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort 25
Safety and Effectiveness of Intensive Treatments Administered Outside the Intensive Care Unit to Hematological Critically Ill Patients: An Intensive Care without Walls Trial 12
Totale 1.099
Categoria #
all - tutte 4.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202052 0 0 0 0 0 6 11 5 7 12 8 3
2020/2021248 6 3 17 19 15 22 16 24 33 40 25 28
2021/2022159 30 19 30 21 9 18 3 0 3 7 6 13
2022/2023190 15 45 24 19 16 30 4 8 8 2 14 5
2023/2024170 7 12 12 16 29 44 20 1 13 4 1 11
2024/2025176 27 43 28 23 34 21 0 0 0 0 0 0
Totale 1.099